Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee
Article first published online: 13 DEC 2005
Copyright © 1993 American College of Rheumatology
Arthritis & Rheumatism
Volume 36, Issue 9, pages 1196–1206, September 1993
How to Cite
James Williams, H., Ward, J. R., Egger, M. J., Neuner, R., Brooks, R. H., Clegg, D. O., Field, E. H., Skosey, J. L., Alarcón, G. S., Willkens, R. F., Paulus, H. E., Jon Russell, I. and Sharp, J. T. (1993), Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. Arthritis & Rheumatism, 36: 1196–1206. doi: 10.1002/art.1780360904
- Issue published online: 13 DEC 2005
- Article first published online: 13 DEC 2005
- Manuscript Accepted: 9 MAR 1993
- Manuscript Received: 22 SEP 1992
- NIAMS. Grant Number: N01-AR-2264
Objective. To compare the relative safety and efficacy of naproxen and acetaminophen in the treatment of osteoarthritis (OA) of the knee. The major outcome measures were radiographic progression and withdrawal from the trial due to lack of efficacy.
Methods. One hundred seventy-eight patients with OA of the knee were enrolled in a 2-year prospective, controlled, double-blind multicenter trial and were randomly assigned to receive acetaminophen (ACT) or naproxen (NPX) treatment.
Results. After 6 weeks of treatment, modest improvement in pain on motion and in physician's global assessment was seen in both the ACT and the NPX groups, and the NPX group also had modest improvement in pain at rest and in 50-foot walk time. Sixty-two patients completed the 2-year study. Among these patients, radiographic progression was similar in the 2 treatment groups. Withdrawal from the trial due to lack of drug efficacy was slightly more frequent among patients in the ACT group (22% versus 16%), but withdrawal due to adverse drug effects was slightly more common in the NPX group (23% versus 18%).
Conclusion. The efficacy of ACT treatment and NPX treatment was similar, although it was slightly better for NPX. The toxicity rate was slightly lower with ACT. However, the high rate of withdrawal in both treatment groups suggests that neither is satisfactory for the treatment of OA.